Literature DB >> 7722012

Current therapy for cutaneous melanoma.

T M Johnson1, J W Smith, B R Nelson, A Chang.   

Abstract

We review the current therapy for melanoma. The diagnosis, prognostic variables, staging, treatment, and follow-up guidelines for cutaneous melanoma are reviewed from the earliest to the most advanced stages. New guidelines for margins are discussed. A new, evolving, innovative radiographic technique, positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose, may be useful to identify subclinical nodal and visceral disease. Recent advances with respect to tumor vaccines, gene therapy, immunotherapy, and interleukin 2 as well as current concepts regarding lymph node dissection are discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7722012     DOI: 10.1016/0190-9622(95)91443-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

1.  Economic evaluation of an educational campaign for early diagnosis of cutaneous melanoma.

Authors:  L Garattini; T Cainelli; G Tribbia; D Scopelliti
Journal:  Pharmacoeconomics       Date:  1996-02       Impact factor: 4.981

2.  In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.

Authors:  Y Sun; P Möller; C Berking; E M Schlüpen; M Volkenandt; D Schadendorf
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

3.  Current biopsy practices for suspected melanoma: A survey of family physicians in Southwestern Ontario.

Authors:  Kristina Lutz; Victoria Hayward; Mariamma Joseph; Eric Wong; Claire Temple-Oberle
Journal:  Plast Surg (Oakv)       Date:  2014       Impact factor: 0.947

4.  Malignant melanoma and pregnancy ten questions.

Authors:  R O Dillman; L A Vandermolen; N M Barth; K J Bransford
Journal:  West J Med       Date:  1996-02

5.  From melanocyte to metastatic malignant melanoma.

Authors:  Bizhan Bandarchi; Linglei Ma; Roya Navab; Arun Seth; Golnar Rasty
Journal:  Dermatol Res Pract       Date:  2010-08-11

6.  Perineural spread of malignant melanoma of the head and neck: clinical and imaging features.

Authors:  Patrick C Chang; Nancy J Fischbein; Timothy H McCalmont; Mohammed Kashani-Sabet; Elizabeth M Zettersten; Amon Y Liu; Jane L Weissman
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

7.  Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.

Authors:  Andrzej Slominski; Blazej Zbytek; Radomir Slominski
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

8.  Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization.

Authors:  I Okamoto; H Pirc-Danoewinata; J Ackermann; J Drach; H Schlagbauer Wadl; B Jansen; K Wolff; H Pehamberger; C Marosi
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

Review 9.  The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.

Authors:  Ibrahim Ragab Eissa; Itzel Bustos-Villalobos; Toru Ichinose; Shigeru Matsumura; Yoshinori Naoe; Noriyuki Miyajima; Daishi Morimoto; Nobuaki Mukoyama; Wu Zhiwen; Maki Tanaka; Hitoki Hasegawa; Seiji Sumigama; Branko Aleksic; Yasuhiro Kodera; Hideki Kasuya
Journal:  Cancers (Basel)       Date:  2018-09-26       Impact factor: 6.639

Review 10.  Adjuvant therapy of melanoma with interferon: lessons of the past decade.

Authors:  Paolo A Ascierto; John M Kirkwood
Journal:  J Transl Med       Date:  2008-10-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.